NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 362 filers reported holding NOVOCURE LTD in Q2 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $7,972,000 | +95.2% | 35,941 | +16.3% | 0.01% | +80.0% |
| Q1 2021 | $4,084,000 | -26.7% | 30,900 | -4.0% | 0.01% | -28.6% |
| Q4 2020 | $5,572,000 | +605.3% | 32,200 | +353.5% | 0.01% | +600.0% |
| Q3 2020 | $790,000 | -60.9% | 7,100 | -79.2% | 0.00% | -66.7% |
| Q2 2020 | $2,023,000 | -53.7% | 34,123 | -47.4% | 0.00% | -66.7% |
| Q1 2020 | $4,370,000 | -1.2% | 64,901 | +23.6% | 0.01% | +12.5% |
| Q4 2019 | $4,424,000 | – | 52,501 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |